We are live on ! Find out more
BBHC

Brown Brothers Harriman & Co Portfolio holdings

AUM $22.8B
1-Year Est. Return 25.09%
This Fund
S&P 500
This Quarter Est. Return
+1.28%
1 Year Est. Return
+25.09%
3 Year Est. Return
+81.82%
5 Year Est. Return
+99.92%
10 Year Est. Return
+339.81%
AUM
$19.2B
AUM Growth
-$117M
Cap. Flow
-$328M
Cap. Flow %
-1.7%
Top 10 Hldgs %
45.98%
Holding
942
New
252
Increased
135
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$439M
2
PYPL icon
PayPal
PYPL
+$34.2M
3
SABR icon
Sabre
SABR
+$24.5M
4
BKU icon
Bankunited
BKU
+$16.1M
5
HEI.A icon
HEICO Corp Class A
HEI.A
+$10.9M

Top Sells

Rank Stock Value
1
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$305M
2
PGR icon
Progressive
PGR
+$56.3M
3
CMCSA icon
Comcast
CMCSA
+$48.9M
4
USB icon
US Bancorp
USB
+$36.9M
5
MSFT icon
Microsoft
MSFT
+$31.7M

Sector Composition

Rank Sector Weight
1 Financials 24.69%
2 Technology 15.58%
3 Healthcare 12.75%
4 Communication Services 11.75%
5 Energy 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MANH icon
551
Manhattan Associates
MANH
$11.2B
$21K ﹤0.01%
+329
New +$20.5K
SNY icon
552
Sanofi
SNY
$105B
$21K ﹤0.01%
500
-400
-44% -$16.4K
INVN
553
DELISTED
Invensense Inc
INVN
$21K ﹤0.01%
3,500
+1,000
+40% +$6.91K
AGNC icon
554
AGNC Investment
AGNC
$12.9B
$20K ﹤0.01%
+1,000
New +$18.9K
IEX icon
555
IDEX
IEX
$17.7B
$20K ﹤0.01%
+246
New +$20.5K
IT icon
556
Gartner
IT
$11.3B
$20K ﹤0.01%
+210
New +$20K
SJM icon
557
J.M. Smucker
SJM
$12.7B
$20K ﹤0.01%
+132
New +$17.6K
STJ
558
DELISTED
St Jude Medical
STJ
$20K ﹤0.01%
250
APH icon
559
Amphenol
APH
$210B
$19K ﹤0.01%
1,320
-1,600
-55% -$23K
CGEN icon
560
Compugen
CGEN
$237M
$19K ﹤0.01%
3,000
GDV icon
561
Gabelli Dividend & Income Trust
GDV
$2.68B
$19K ﹤0.01%
1,000
-3,000
-75% -$56.2K
JKHY icon
562
Jack Henry & Associates
JKHY
$10.8B
$19K ﹤0.01%
+217
New +$18.1K
LSTR icon
563
Landstar System
LSTR
$6.31B
$19K ﹤0.01%
+274
New +$18.1K
MORN icon
564
Morningstar
MORN
$7.41B
$19K ﹤0.01%
+238
New +$19.9K
STI
565
DELISTED
SunTrust Banks, Inc.
STI
$19K ﹤0.01%
+451
New +$18.4K
ES icon
566
Eversource Energy
ES
$26.9B
$18K ﹤0.01%
294
-106
-27% -$6K
ETN icon
567
Eaton
ETN
$179B
$18K ﹤0.01%
306
+211
+222% +$13K
ZBH icon
568
Zimmer Biomet
ZBH
$18.7B
$18K ﹤0.01%
155
+78
+101% +$8.83K
AKBA icon
569
Akebia Therapeutics
AKBA
$248M
$17K ﹤0.01%
+2,318
New +$20.2K
AMKR icon
570
Amkor Technology
AMKR
$13.8B
$17K ﹤0.01%
2,985
HOLX
571
DELISTED
Hologic
HOLX
$17K ﹤0.01%
+500
New +$17.3K
KIM icon
572
Kimco Realty
KIM
$16.2B
$17K ﹤0.01%
526
+26
+5% +$749
KN icon
573
Knowles
KN
$3.33B
$17K ﹤0.01%
1,275
XLE icon
574
State Street Energy Select Sector SPDR ETF
XLE
$39.9B
$17K ﹤0.01%
484
-172
-26% -$5.68K
BHI
575
DELISTED
Baker Hughes
BHI
$17K ﹤0.01%
372
+301
+424% +$13.6K

Similar funds

Brown Brothers Harriman & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Brown Brothers Harriman & Co held 942 positions worth $19.2B, down 0.61% from $19.4B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Brown Brothers Harriman & Co's Q2 2016 filing shows 252 new, 135 increased, 217 reduced and 105 closed positions. Its largest new stake was Sabre: 872,000 shares worth $23.4M. The largest sale was BAXALTA INC COM STK (DE), an estimated $305M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

  • Brown Brothers Harriman & Co's largest Q2 2016 buy was Sabre: 872,000 shares worth $23.4M.
  • Brown Brothers Harriman & Co added most to Perrigo in Q2 2016, an estimated $439M increase.
  • Brown Brothers Harriman & Co's biggest Q2 2016 reduction was Progressive, cutting an estimated $56.3M.
  • Brown Brothers Harriman & Co fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $305M.
  • Brown Brothers Harriman & Co's ten largest holdings make up 46% of its $19.2B portfolio in Q2 2016.
  • Brown Brothers Harriman & Co opened 252 new positions and closed 105 in Q2 2016.
  • Brown Brothers Harriman & Co's portfolio value fell 0.61% quarter-over-quarter to $19.2B.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2016, filed 15 Aug 2016.